InMed Pharmaceuticals (INM) Interest & Investment Income (2019 - 2026)
InMed Pharmaceuticals (INM) posted Interest & Investment Income of $47770.0 for Q1 2026, down 35.77% on a QoQ basis from $74379.0 in Q4 2025, and up 188.38% year-over-year from $16565.0 in Q1 2025.
Powered by 
Analysis
InMed Pharmaceuticals (INM) Interest & Investment Income (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals has reported Interest & Investment Income for 8 years, with the latest figure at $47770.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 188.38% year-over-year to $47770.0 in Q1 2026; TTM through Mar 2026 was $267601.0, a 28.76% increase from a year earlier, with the FY2025 full-year figure at $155882.0, down 70.47% from the prior year.
- Interest & Investment Income was $47770.0 for Q1 2026 at InMed Pharmaceuticals, down from $74379.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $166760.0 in Q4 2023, with the low at $16565.0 in Q1 2025.
- Average Interest & Investment Income over 5 years is $85694.2, with a median of $74379.0 recorded in 2025.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 1310.0% in 2022, then plunged 86.36% in 2025.
- Over 5 years, Interest & Investment Income stood at $115797.0 in 2022, then surged by 44.01% to $166760.0 in 2023, then plunged by 81.69% to $30536.0 in 2024, then soared by 143.58% to $74379.0 in 2025, then plunged by 35.77% to $47770.0 in 2026.
- The last three Interest & Investment Income figures came in at $47770.0 (Q1 2026), $74379.0 (Q4 2025), and $93765.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Corning | 145.48 Bn | 142.98 Bn | 1.63 Bn | 12.00 Mn |
| 2 | Ati | 28.41 Bn | 27.63 Bn | 309.80 Mn | -23.90 Mn |
| 3 | Qnity Electronics | 26.25 Bn | 25.29 Bn | 666.00 Mn | - |
| 4 | International Flavors & Fragrances | 21.54 Bn | 20.97 Bn | 853.00 Mn | - |
| 5 | DuPont de Nemours | 17.57 Bn | 15.83 Bn | 639.00 Mn | - |
| 6 | Avery Dennison | 12.97 Bn | 12.75 Bn | 729.40 Mn | - |
| 7 | Solstice Advanced Materials | 10.10 Bn | 9.35 Bn | 370.00 Mn | - |
| 8 | Element Solutions | 8.81 Bn | 8.62 Bn | 334.00 Mn | -24.00 Mn |
| 9 | Eastman Chemical | 7.85 Bn | 7.16 Bn | 560.00 Mn | - |
| 10 | InMed Pharmaceuticals | 5.31 Mn | 69,625.35 | - | 47,770.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 47,770.00 |
| Dec 31, 2025 | 74,379.00 |
| Sep 30, 2025 | 93,765.00 |
| Jun 30, 2025 | 51,687.00 |
| Mar 31, 2025 | 16,565.00 |
| Dec 31, 2024 | 30,536.00 |
| Sep 30, 2024 | 57,094.00 |
| Jun 30, 2024 | 103,640.00 |
| Mar 31, 2024 | 121,458.00 |
| Dec 31, 2023 | 166,760.00 |
| Sep 30, 2023 | 136,043.00 |
| Jun 30, 2023 | 148,559.00 |
| Mar 31, 2023 | 155,497.00 |
| Dec 31, 2022 | 115,797.00 |
| Sep 30, 2022 | 72,587.00 |
| Jun 30, 2022 | 33,701.00 |
| Mar 31, 2022 | 30,964.00 |
| Dec 31, 2021 | 26,277.00 |
| Sep 30, 2021 | 5,148.00 |
| Jun 30, 2021 | 4,825.00 |